Patent Strategy Presentations

  1. ​​"Patently Strategic: Patent Strategy for Entrepreneurs." SPARK, Ann Arbor, Michigan, 04/2016. 
  2. "Intellectual Property 101." SPARK, Ypsilanti, Michigan, 04/2017.
  3. "Glimpses of Hope: Protecting Software Innovations After Alice." Bar Association of San Francisco; Litigation Section, San Francisco, California, 05/2017.
  4. "Intellectual Property 101." SPARK, Ypsilanti, Michigan, 08/2017.
  5. "Protecting Cannabis-Related Innovations." Michigan Bar Association; Marijuana Legal Section, Detroit, Michigan, 09/2017. 
  6. "Intellectual Property 101." 20Fathoms, Traverse City, Michigan, 11/2018.
  7. "BIOLOGY - outside the body and into the workforce." Lake City Career Day, Lake City, Michigan, 04/2019.
  8. "Dealing with Patents in the Cannabis Industry." NORML, Aspen, Colorado, 05/2019.

Research Presentations

  1. “Identifying Novel Targets and Pathways Regulated by Notch Signaling in T Cells.” Stem Cell Club, Life Sciences Institute, 02/2009.
  2. “Identifying Novel Targets and Pathways Regulated by Notch Signaling in T Cells.” Mouse genetics interest group, Mouse Club, 04/2009.
  3. “Identifying Novel Targets and Pathways Regulated by Notch Signaling in T Cells.” Cell and Developmental Biology Group Meeting, 08/2009.
  4. “Notch Signaling is a Critical Regulator of Allogeneic T Cell Responses Mediating Graft-versus-host Disease.” Cell and Developmental Biology Retreat, 10/2009.
  5. “Molecular Dissection of Notch Signaling in Alloimmune T cell Responses.” Mouse genetics interest group, Mouse Club, 04/2010.
  6. “Notch signaling after allogeneic hematopoietic stem cell transplantation.” Stem Cell Club, Life Sciences Institute, 05/2010.
  7. “Molecular Dissection of Notch Signaling in Alloimmune T cell Responses.” Cell and Developmental Biology Group Meeting, 05/2010.
  8. “Notch signaling in allogeneic and autoimmune responses.” Autoimmune disease interest group, Joint Lab Meeting, 11/2010.
  9. “Notch signaling is a critical regulator of alloimmune T cell responses mediating graft-versus-host disease.” Immunology Program Seminar Series, 2/2011.
  10. “Notch signaling is a critical regulator of alloimmune and MOG-reactive T cell responses.” Autoimmune disease interest group, Joint Lab Meeting, 06/2011.
  11. “Notch signaling in alloimmunity and autoimmunity.” Stem Cell Club, Life Sciences Institute, 06/2011.
  12. “Notch signaling in alloimmunity and autoimmunity.” Notch Club, 07/2011.
  13. “Notch signaling is a critical regulator of alloimmune and autoreactive T cell responses.” Immunology Program Seminar Series, 2/2012.
  14. “Notch signaling is a critical regulator of alloimmune and autoreactive T cell responses.” Cell and Developmental Biology Group Meeting, 02/2012.
  15. “New mechanisms of Notch action in alloreactive T cells.” Life Sciences Institute Colloquium, 03/2012.
  16. “Notch signaling is a critical regulator of MOG-reactive CD4+ T cell responses during experimental autoimmune encephalomyelitis.” Cell and Developmental Biology Group Meeting, 11/2012.
  17. “Notch signaling is a critical regulator of CNS-infiltrating MOG-reactive CD4+ T cell during experimental autoimmune encephalomyelitis. Immunology Program Seminar Series, 01/2013.
  18. “The role of Notch signaling in T cell-mediated immune disorders.” Graduate Program in Immunology Thesis Defense, 04/2013.

Abstracts and Poster Presentations

  1. Sandy AR, Hoselton S, Schuh J, Dorsam G. Elevated Ikaros Expression Profiles in Fungal-Sensitized CD11b+ Lung Leukocytes. Poster presentation. ASBMB Conference. Moorehead, MN 10/2006.
  2.  Sandy AR, Hoselton S, Schuh J, Dorsam G. Elevated Ikaros Expression Profiles in Fungal-Sensitized CD11b+ Lung Leukocytes. Poster presentation. Department of Chemistry and Molecular Biology, North Dakota State University. Fargo, ND, 05/2007.
  3. Sandy AR, Failing J, Vomhof-DeKrey E, Hoselton S, Schuh J, Dorsam G. The Tumor Suppressor Ikaros Transcription Factor is Crucial for the Anti-Proliferative Vasoactive Intestinal Peptide Receptor-1 Expression in Developing Thymocytes. Poster presentation. ASBMB Conference. Moorehead, MN 10/2007.
  4. Sandy AR, Failing J, Vomhof-DeKrey E, Hoselton S, Schuh J, Dorsam G. The Tumor Suppressor Ikaros Transcription Factor is Crucial for the Anti-Proliferative Vasoactive Intestinal Peptide Receptor-1 Expression in Developing Thymocytes. Poster presentation. Centers of Biomedical Research Excellence Meeting. Fargo, ND, 01/2008.
  5. Sandy AR, Failing J, Vomhof-DeKrey E, Hoselton S, Schuh J, Dorsam G. The Tumor Suppressor Ikaros Transcription Factor is Crucial for the Anti-Proliferative Vasoactive Intestinal Peptide Receptor-1 Expression in Developing Thymocytes. Poster presentation. ASBMB/FASEB Meeting. San Diego, CA, 04/2008.
  6. Sandy AR, Failing J, Vomhof-DeKrey E, Hoselton S, Schuh J, Dorsam G. The Tumor Suppressor Ikaros Transcription Factor is Crucial for the Anti-Proliferative Vasoactive Intestinal Peptide Receptor-1 Expression in Developing Thymocytes. Poster presentation. Department of Chemistry and Molecular Biology, North Dakota State University. Fargo, ND, 05/2008.
  7. Sandy AR, Failing J, Vomhof-DeKrey E, Hoselton S, Schuh J, Dorsam G. The Tumor Suppressor Ikaros Transcription Factor is Crucial for the Anti-Proliferative Vasoactive Intestinal Peptide Receptor-1 Expression in Developing Thymocytes. Poster presentation. Centers of Biomedical Research Excellence Meeting. Fargo, ND, 06/2008.
  8. Sandy AR, Shan GT, Tran IT, Friedman A, Wang J, He S, Hexner E, Frank D, Emerson SG, Pear WS, Zhang Y, Maillard I. Notch signaling critically regulates multiple effector functions of alloreactive T cells during graft-versus-host disease Poster presentation. Cold Spring Harbor Laboratory Spring Meeting.  Gene Expression and Signaling in the Immune System. Cold Spring Harbor, NY, 04/2010.
  9. Sandy AR, Tran IT, Shan GT, Friedman A, Wang J, Kato K, He S, Hexner E, Emerson SG, Pear WS, Zhang Y, Maillard I. Notch Signaling is a Critical Regulator of Allogeneic T cell Responses Mediated Graft-versus-Host Disease. Oral and poster presentation. Autumn Immunology Conference, Chicago, IL, 11/2010.
  10. Tran IT, Sandy AR, Shan GT, Radojcic V, Friedman A, Shelton A, Yan M, Siebel CW, Maillard I. Inhibition of individual Notch ligands and receptors provides a new targeted therapeutic approach in graft-versus-host disease. University of Michigan Department of Internal Medicine Research Day, Ann Arbor, MI, 05/2011.
  11. Sandy AR, Rao P, Pongtornpipat P, Segal B, Maillard I. Notch signaling is a critical regulator of myelin-reactive T cells mediating experimental autoimmune encephalomyelitis. 2011 Graduate Program in Immunology Retreat, Ann Arbor, MI, 05/2011.
  12. Sandy AR, Chung J, Tran IT, Shan GT, Friedman A, King PD, Zhang Y, Maillard I. Notch signaling critically regulates CD4+ and CD8+ T cell responses after allogeneic bone marrow transplantation. The Notch Meeting, Athens, Greece, 10/2011.
  13. Tran IT, Sandy AR, Carulli A, Shan GT, Radojcic V, Friedman A, Shelton A, Samuelson L, Yan M, Siebel CW, Maillard I. In vivo blockade of individual Notch ligands and receptors provides a new targeted therapeutic approach in graft-versus-host disease. American Society of Hematology Annual Meeting and Exposition, San Diego, CA, 12/2011.
  14. Ebens CL, Chung J, Koch U, Tran IT, Sandy AR, Yu A, Friedman A, Yan M, Siebel CW, Radtke F, Maillard I. Identification of Notch Ligand Source in Acute Graft-Versus-Host Disease. Oral Presentation. 23rd Annual Pediatric Research Symposium. Ann Arbor, MI 10/2012. 
  15. Sandy AR, Chung J, Tran IT, Shan GT, Friedman A, Blackwell TS, Reddy P, King PD, Maillard I. Notch inhibition in alloreactive CD4+ and CD8+ T cells blocks graft-versus-host disease by inducing a hyporesponsive program with features of split T cell anergy. Oral presentation. American Society of Hematology Meeting. Atlanta, GA 12/2012. 
  16. Xing X, Cho WS, Qiu Y, Chung J, Sandy-Sloat AR, Malachowski AN, Eastman AJ, Maillard I, Olszewski MA. T-cell Restricted Notch Signaling Promotes Immune Protection Against C. Neoformans in Infected Mice. 4th Annual Midwest Neglected Infectious Diseases Meeting. Notre Dame, IN 08/2014.